Skip to content

Clinical trials

Completed Phase 2 Ocular Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ocular Hypertension Phase: Phase 2 Status: Completed Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20052
20064
20078
20084
20099
20107
20119
20127
20138
20148
20153
20162
20173
20181
20193
20202
20215
20222
20232
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed101

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research18
Aerie Pharmaceuticals13
Mati Therapeutics Inc.10
Allergan8
Santen Inc.6
Qlaris Bio, Inc.5
ForSight Vision5, Inc.4
Bausch & Lomb Incorporated3
Amakem, NV2
Inotek Pharmaceuticals Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ocular Hypertension101
Glaucoma, Open-Angle75
Glaucoma49
Hypertension5
Eye Diseases3
Sturge-Weber Syndrome2
Exfoliation Syndrome1
Hydrophthalmos1

Trials

Showing 1 to 25 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.